JapanKobayashi Pharmaceutical held a press conference in Osaka city this afternoon (29th), revealing that red yeast rice health food caused consumers to become ill and even cause five deaths. Asked about the harm to the health of consumers outside Japan, executive director Watanabe said that foreign consumers would certainly receive similar compensation. President Akihiro Kobayashi said he had learned that a consumer in Taiwan had been victimized and was setting up a local telephone consultation window as soon as possible.
Online questions from the media will also be accepted simultaneously with the press conference.hong kongAccording to media inquiries, the press materials released by Kobayashi Pharmaceutical are not available in Chinese or English, but it is known that there is also a victim in Taiwan. Kobayashi apologized for the trouble caused by the press release. He said Taiwan is a supplier of raw materials produced by Kobayashi Pharmaceutical, and the raw materials come to Taiwan through sales or wholesale. It is currently unknown what types of products are sold in Taiwan, and we urge them to be removed from shelves for recycling.
A woman in Kaohsiung started taking Daiichi’s “red yeast capsules” in March last year. The raw material of red yeast in capsules comes from Kobayashi Pharmaceutical.
He said the company has learned through the media that a person has been victimized in Taiwan, and does not currently know whether the product comes from wholesale or local manufacturers. Kobayashi said that since a telephone consultation system has not yet been established, Kobayashi Pharmaceutical is sending a person in charge there as soon as possible to set up a consultation hotline. Japanese companies also plan to issue local press releases.
Watanabe said he has been in contact with the families of the three dead people in Japan and met with one of them to discuss compensation. As far as consumers whose health has deteriorated are concerned, they are negotiating compensation with those who are undergoing treatment and hospitalisation. Consumers who have gone to the doctor are also discussing paying the medical bill. The targets of compensation include 114 people who have been hospitalized and 680 people who have received medical treatment.
President Kobayashi said the scope and amount of compensation were still unclear. However, he admitted that this food safety crisis has caused the company at least more than 1.8 billion yen in losses, and this amount will increase again. As for products other than those declared for recycling, They will not be accepted.pharmacyAspects of return.
International(TagstoTranslate)Japan(T)Hong Kong(T)Pharmacy